December 28, 2008

AICC members work together: SGR Advises Given Imaging in Acquisition of Medtronic’s Bravo

SGR Advises Given Imaging in Acquisition of Medtronic’s Bravo pH Monitoring Business ATLANTA (December 18, 2008) — On December 8th, a group of Smith, Gambrell & Russell attorneys assisted client Given Imaging Ltd. in finalizing the acquisition of the Bravo(R) pH monitoring business for the diagnosis of Gastroesophageal Reflux Disease (GERD) from Medtronic (NYSE: MDT) for $20 million. Jay Schwartz was […]
December 11, 2008

AICC Member Given Imaging buys product line from Medtronic

Published by: Globes 12/09/2008 The new operations in Israel are expected to create 30-40 jobs. Capsule imaging developer Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) has bought the Bravo pH monitoring business for diagnosing Gastroesophageal Reflux Disease (GERD) from Medtronic (NYSE: MDT) for $20 million. The Bravo system uses a disposable capsule temporarily placed in the esophagus that measures pH […]